The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Vera Therapeutics Inc (NASDAQ: VERA) closed at $46.71 in the last session, up 4.82% from day before closing price of $44.56. In other words, the price has increased by $4.82 from its previous closing price. On the day, 0.54 million shares were traded. VERA stock price reached its highest trading level at $46.82 during the session, while it also had its lowest trading level at $42.93.
Ratios:
We take a closer look at VERA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.15 and its Current Ratio is at 21.15. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On December 18, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on December 18, 2023, with a $29 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 19 ’24 when SEIDENBERG BETH C sold 13,823 shares for $42.31 per share. The transaction valued at 584,793 led to the insider holds 146,553 shares of the business.
SEIDENBERG BETH C sold 1,476 shares of VERA for $61,992 on Sep 18 ’24. The Director now owns 4,012 shares after completing the transaction at $42.00 per share. On Sep 18 ’24, another insider, SEIDENBERG BETH C, who serves as the Director of the company, sold 1,177 shares for $42.01 each. As a result, the insider received 49,448 and left with 160,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2561001728 and an Enterprise Value of 2229447168.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $50.78, while it has fallen to a 52-week low of $9.24. The 50-Day Moving Average of the stock is 24.21%, while the 200-Day Moving Average is calculated to be 30.99%.
Shares Statistics:
According to the various share statistics, VERA traded on average about 555.05K shares per day over the past 3-months and 781110 shares per day over the past 10 days. A total of 44.45M shares are outstanding, with a floating share count of 41.54M. Insiders hold about 24.24% of the company’s shares, while institutions hold 90.10% stake in the company. Shares short for VERA as of 1724976000 were 6047559 with a Short Ratio of 10.90, compared to 1722384000 on 6087889. Therefore, it implies a Short% of Shares Outstanding of 6047559 and a Short% of Float of 16.27.
